Psychiatry & Neurology, Child & Adolescent Psychiatry · Wayne, PA
NPI
1972623445
Since 2007
Specialty
Psychiatry & Neurology, Child & Adolescent Psychiatry
Code 2084P0804X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
121 N Wayne Ave, Suite 300
Wayne, PA, 19087
Phone (610) 975-9435
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$287K
2,769 prescriptions
Company payments, 2025
$1,341
From 13 companies
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey A Naser prescribed most often to Medicare patients was Lorazepam, with 162 prescriptions and refills. In total Jeffrey A Naser wrote 2,769 Medicare prescriptions that cost $287K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Lorazepam Generic | 162 | 187 | 27 | $1,696 |
| Fluoxetine Hcl Generic | 151 | 263 | 26 | $5,500 |
| Sertraline Hcl Generic | 136 | 161 | 13 | $1,056 |
| Quetiapine Fumarate Generic | 132 | 173 | 12 | $2,820 |
| Clonazepam Generic | 131 | 147 | 16 | $1,090 |
| Aripiprazole Generic | 105 | 155 | 17 | $9,972 |
| Duloxetine Hcl Generic | 91 | 139 | 11 | $1,561 |
| Bupropion Xl Bupropion Hcl | 80 | 144 | 15 | $1,955 |
| Vraylar Cariprazine Hcl | 73 | 76 | Under 11 | $112K |
| Risperidone Generic | 71 | 114 | Under 11 | $1,610 |
| Lamotrigine Generic | 70 | 80 | Under 11 | $298 |
| Escitalopram Oxalate Generic | 65 | 85 | Under 11 | $733 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 65 | 69 | 12 | $1,538 |
| Dexmethylphenidate Hcl Er Dexmethylphenidate Hcl | 62 | 72 | Under 11 | $3,034 |
| Benztropine Mesylate Generic | 61 | 62 | Under 11 | $840 |
Brand drugs: 225 claims; generic drugs: 2,544 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey A Naser $1,341 ($1,341 in general payments such as food, travel and fees) from 13 companies. The largest payer was Axsome Therapeutics, Inc. with $350.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 19 | $350 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 27 | $303 |
| Abbvie Inc. ABBV | 17 | $243 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $131 |
| Supernus Pharmaceuticals, Inc. SUPN | 5 | $86.08 |
| Collegium Pharmaceutical, Inc. COLL | 3 | $63.51 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 2 | $36.77 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $30.27 |
| Bausch Health US, LLC BHC | 1 | $22.21 |
| Corium, LLC | 3 | $20.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.